Clinical trial
Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of…
NCT00232765 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00232765 |
|---|---|
| Title | Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS) |
| Official title | A Multicenter, Randomized, Double-Blind Study of the Sirolimus-Coated BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | CYPHER Sirolimus-Eluting Stent, Uncoated BX VELOCITY Balloon-Expandable Stent |
| Enrollment | 1,058 |
| Start date | Feb 1, 2001 |
| Primary completion | May 1, 2002 |
| Completion | Nov 1, 2008 |
| First posted | Oct 5, 2005 |
| Last update posted | Sep 16, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: